July, 2022
During the 2022 American Transplant Congress (ATC) in Boston, MA, the AST held the inaugural Living Donor Circle of Excellence Reception, which honored living donors and the companies that offer paid leave to employees who choose to become living donors.
During the event, the AST presented awards to the Circle of Excellence Founding Partner, UnitedHealth Group, and to its Strategic Partners, the National Kidney Foundation, The Kidney Foundation of Canada, and the Canadian Society of Transplantation.
Launched in 2020, the
Living Donor... Read More...
June, 2022
The American Society of Transplantation (AST) is a diverse organization dedicated to advancing the field of transplantation and improving patient care by promoting research, education, advocacy, organ donation, and service to the community through a lens of equity and inclusion. We are committed to supporting and guiding our patients and health care providers through all aspects of pre- and post-transplant care, including reproductive care. We provide this statement primarily to protect the health of our patients.
On June 24, 2022, the Supreme Court overturned the Roe vs. Wade US Supreme...
Read More...
The American Society of Transplantation (AST) announced the recipients of its
2022 Achievement Awards at the recent American Transplant Congress (ATC) on June 5, 2022. The recipients were awarded for their achievements and contributions to the AST and the field of transplantation.
The AST posthumously awarded the 2022 Lifetime Achievement Award to Dr. Barbara Murphy. Learn more about Dr. Murphy
here.
A list of previous Lifetime...
Read More...
The American Society of Transplantation (AST) announced its newly elected 2022-2023 Board Members, including its new President, President-Elect, Treasurer, and Councilors-at-Large. The results were announced during the 2022 AST Town Hall, on June 6, 2022.
Dr. Deepali Kumar assumed the role of AST President after serving as the Society’s President-Elect. Dr. Kumar is a transplant infectious diseases physician in the Multi-Organ Transplant Program at University Health Network in Toronto.
Dr. John Gill, a Professor of Medicine with tenure at British Columbia in Vancouver, Canada, previously...
Read More...
April, 2022
The American Society of Transplantation and the National Kidney Foundation (NKF) are proud to announce their strategic partnership with the Living Donor Circle of Excellence program. The Circle of Excellence seeks to increase the number of living organ donors by recognizing employers that provide lost wages while donors recover from surgery. To view the full press release,
click here.
The AST is pleased to announce the results of the 2022-2023 Communities of Practice (COP) Executive Committee (EC) elections. To view the full list,
click here.
Jennifer McDermott, PharmD, BCTXP, BCPS on behalf of the AST Transplant Pharmacy COP Public Policy Workgroup
The AST Transplant Pharmacy COP Public Policy Workgroup has been working on an important initiative for several years with the support of the AST Transplant Pharmacy COP Executive Committee and AST leadership. We are happy to share recent progress that will allow for broader medication access for solid organ transplant recipients.
As a compendium recognized by the Centers for Medicare and Medicaid Services (CMS), Medicare Part D plans utilize the information in IBM-Micromedex® for...
Read More...
February, 2022
Sam Strober, MD, passed away at his home in California on Friday, February 11th. Sam was a friend to many of us and a giant in the field of allograft tolerance induction. He was a Professor of Medicine at Stanford University and remained dedicated to his professional goals until the time of his death from multiple myeloma. Sam devoted his career to the translation of his pioneering work in rodents using total lymphoid irradiation and anti-lymphocyte serum to achieve stable mixed chimerism without graft-vs-host disease into a protocol that can be applied to adult human organ transplant...
Read More...
January, 2022
The FDA publishes this device shortages list to provide transparency to the American public, particularly those who use or purchase medical devices. The list fulfills a statutory obligation under section 506J of the FD&C Act and reflects the categories of devices the FDA has determined to be in shortage at this time and will be maintained and updated as the COVID-19 public health emergency evolves. The presence of a device type on this list does not necessarily indicate that patient care has been affected.
During the COVID-19 public health emergency, the FDA has taken many actions to...
Read More...
November, 2021
We have been made aware of disruptions in the supply of UW Solution to some OPOs. Some suppliers have imposed caps on the amount of UW that can be ordered by a single entity to ensure an adequate supply to all their customers. We have reached out to the suppliers and offered our assistance with any regulatory or other governmental issues they may have that are impacting their supply of UW. In addition, we are coordinating our efforts with AST, ASTS, and UNOS.
In the near term, if you are having issues with obtaining adequate UW supplies, we recommend you check with multiple suppliers as the...
Read More...
